Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 19, 2023
November 27, 2023
532afdaa-2167-4373-8507-eb06f5184eff
Related Documents
Labeling of Red Blood Cell Units with Historical Antigen Typing Results: Guidance for Industry
Guidance DocumentDecember 20, 2018Center for Biologics Evaluation and Research
Compliance Policy Regarding Blood and Blood Component Donation Suitability, Donor Eligibility and Source Plasma Quarantine Hold Requirements: Guidance for Industry
Guidance DocumentOctober 17, 2023Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.